Healthcare - Sector
Epizyme's activity chart (see below) currently has 92 price targets and 79 ratings on display.
Analysts' price targets on this stock were met 56.61% of the time, taking 438.64 days on average.
Most recent stock forecast was given by from TD COWEN on 28-Jun-2022. First documented stock forecast 12-Sep-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Apr-2021
$1.5
$12
4 years 4 months 24 days ago
(28-Jun-2022)
1/3 (33.33%)
$0.02 (1.35%)
38
Hold Since 28-Jun-2022
$1.5
4 years 4 months 24 days ago
(28-Jun-2022)
2/4 (50%)
$0.02 (1.35%)
161
Buy Since 24-Apr-2018
$30
4 years 4 months 25 days ago
(27-Jun-2022)
2/5 (40%)
$12.54 (71.82%)
611
Buy Since 13-Jun-2019
4 years 5 months 18 days ago
(03-Jun-2022)
2/2 (100%)
$13 (108.33%)
808
Sell Since 10-Aug-2021
$5
5 years 3 months 11 days ago
(10-Aug-2021)
4/8 (50%)
$-0.5 (-9.09%)
70
What is EPZM (Epizyme) average time for price targets to be met?
Which analyst most recently updated their price target on EPZM (Epizyme)?
Which analyst has the most public recommendations on EPZM (Epizyme)?
Which analyst is the currently most bullish on EPZM (Epizyme)?
Which analyst is the currently most reserved on EPZM (Epizyme)?